(Senior) Medical Science Liaison - Heartland
TempusFull Time
Senior (5 to 8 years)
Key technologies and capabilities for this role
Common questions about this position
Candidates need an advanced degree (MD, PhD, PharmD preferred) or a master’s degree with solid field experience, minimum 2 years in an MSL or related role, demonstrated oncology expertise in solid tumors, deep understanding of clinical trial execution, fluency in Portuguese and English, Spanish proficiency desirable, authorization to work in Brazil or Argentina, willingness to travel extensively, and a valid driver’s license.
The role requires extensive travel within Brazil and Argentina, including on-site support at clinical trial sites, representing the program at regional scientific meetings, and building relationships with HCPs and KOLs.
This information is not specified in the job description.
The role offers a collaborative, scientific environment with a global MSL network across over two dozen countries, emphasizing cross-functional teamwork, strategic engagement, and direct impact through expertise.
Strong candidates have an advanced degree, oncology expertise especially in solid tumors, MSL experience, fluency in Portuguese and English, and a passion for science and patient care to drive trial excellence.
Advanced analytics and clinical research services
IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.